HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tinghong Ye Selected Research

hinokiflavone

9/2019Antitumor activity in colorectal cancer induced by hinokiflavone.
7/2018Hinokiflavone induces apoptosis in melanoma cells through the ROS-mitochondrial apoptotic pathway and impairs cell migration and invasion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tinghong Ye Research Topics

Disease

38Neoplasms (Cancer)
06/2022 - 08/2013
16Neoplasm Metastasis (Metastasis)
06/2022 - 01/2014
10Breast Neoplasms (Breast Cancer)
07/2021 - 01/2014
8Melanoma (Melanoma, Malignant)
06/2022 - 02/2016
6Pulmonary Fibrosis (Fibrosing Alveolitis)
02/2022 - 01/2017
6Inflammation (Inflammations)
01/2022 - 02/2015
6Autoimmune Hepatitis
04/2020 - 01/2018
5Fibrosis (Cirrhosis)
01/2022 - 01/2018
5Liver Cirrhosis (Hepatic Cirrhosis)
10/2021 - 08/2017
4Colorectal Neoplasms (Colorectal Cancer)
11/2019 - 01/2014
3Autoimmune Diseases (Autoimmune Disease)
01/2021 - 04/2020
3Liver Diseases (Liver Disease)
10/2020 - 04/2018
2Idiopathic Pulmonary Fibrosis
01/2022 - 11/2021
2Triple Negative Breast Neoplasms
12/2021 - 07/2021
2Hypoxia (Hypoxemia)
01/2021 - 04/2014
2Hepatitis
01/2021 - 10/2019
2Carcinoma (Carcinomatosis)
07/2018 - 10/2016
2Pancreatic Neoplasms (Pancreatic Cancer)
07/2016 - 12/2014
2Lung Neoplasms (Lung Cancer)
04/2014 - 08/2013
1Stomach Neoplasms (Stomach Cancer)
10/2022
1Diabetic Nephropathies (Diabetic Nephropathy)
02/2022
1Ovarian Neoplasms (Ovarian Cancer)
01/2022
1Lung Diseases (Lung Disease)
01/2022
1Pathologic Processes
11/2021
1Glomerulonephritis
10/2020
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2020
1Rheumatoid Arthritis
04/2020
1Osteosarcoma (Osteogenic Sarcoma)
10/2019
1Drug-Related Side Effects and Adverse Reactions
09/2019

Drug/Important Bio-Agent (IBA)

18Pharmaceutical PreparationsIBA
02/2022 - 01/2014
14Biological ProductsIBA
10/2022 - 12/2016
9Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2017
6Bleomycin (Blenoxane)FDA LinkGeneric
02/2022 - 01/2017
6Concanavalin AIBA
01/2021 - 01/2018
4nifuroxazide (Akabar)IBA
06/2022 - 02/2016
4MicroRNAs (MicroRNA)IBA
01/2021 - 01/2018
3Matrix Metalloproteinases (MMPs)IBA
11/2021 - 02/2016
3pectolinarigeninIBA
10/2020 - 01/2019
3cryptotanshinoneIBA
10/2020 - 08/2016
3Reactive Oxygen Species (Oxygen Radicals)IBA
10/2020 - 01/2015
3NiclosamideFDA Link
11/2019 - 01/2014
3Caspase 3 (Caspase-3)IBA
09/2019 - 09/2017
2Phosphotransferases (Kinase)IBA
10/2022 - 10/2018
2Therapeutic UsesIBA
02/2022 - 09/2017
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022 - 04/2014
2VimentinIBA
01/2022 - 02/2016
2snake venom protein C activatorIBA
11/2021 - 10/2020
2Carbon Tetrachloride (Tetrachloromethane)IBA
10/2021 - 01/2018
2indium-bleomycinIBA
07/2021 - 01/2017
2Trifluoperazine (Stelazine)FDA LinkGeneric
01/2021 - 01/2019
2Antipsychotic Agents (Antipsychotics)IBA
01/2021 - 01/2019
2Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
10/2020 - 04/2014
2hinokiflavoneIBA
09/2019 - 07/2018
2LigandsIBA
01/2019 - 08/2013
2Liposomes (Liposome)IBA
09/2017 - 01/2017
2Sirolimus (Rapamycin)FDA Link
12/2016 - 04/2014
2ZLD1039IBA
02/2016 - 01/2016
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
10/2022
1AminesIBA
10/2022
1tyrosine receptor (receptor, tyrosine)IBA
10/2022
1Hydroxyproline (4 Hydroxyproline)IBA
02/2022
1Focal Adhesion Protein-Tyrosine KinasesIBA
01/2022
1CollagenIBA
01/2022
1Cadherins (E-Cadherin)IBA
01/2022
1Platelet-Derived Growth FactorIBA
01/2022
1Casein Kinase II (Casein Kinase 2)IBA
12/2021
1Matrix Metalloproteinase InhibitorsIBA
11/2021
1Histones (Histone)IBA
11/2021
1N-methyladenosineIBA
11/2021
1MTOR InhibitorsIBA
07/2021
1Cytostatic AgentsIBA
07/2021
1IndazolesIBA
04/2021
1Circular RNAIBA
01/2021
1Glucose (Dextrose)FDA LinkGeneric
01/2021
1Endothelial Protein C ReceptorIBA
01/2021
1Neuropilin-1IBA
01/2021
1galanginIBA
10/2020
1Chimeric Antigen ReceptorsIBA
10/2020
1PhytochemicalsIBA
10/2020
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
10/2020
1GlucosidesIBA
04/2020
1Nucleic AcidsIBA
01/2020
1chenodeoxycholate sulfate conjugate (CDCS)IBA
01/2020
1LipidsIBA
01/2020
1Caveolin 2IBA
01/2020
1Matrix Metalloproteinase 2 (Gelatinase A)IBA
11/2019
1TriazolesIBA
10/2019
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2019
1Anti-Bacterial Agents (Antibiotics)IBA
10/2019
1Alanine Transaminase (SGPT)IBA
10/2019
1pyridineIBA
10/2019
1Hematoxylin (Haematoxylon)IBA
09/2019
1Antineoplastic Agents (Antineoplastics)IBA
09/2019
1Eosine Yellowish-(YS) (Eosin)IBA
09/2019
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2019

Therapy/Procedure

22Therapeutics
10/2022 - 01/2014
3Drug Therapy (Chemotherapy)
01/2021 - 09/2017
2Immunotherapy
01/2021 - 10/2020
2Oral Administration
10/2018 - 08/2014
1Intraperitoneal Injections
02/2022